Mast Cell Survival and Mediator Secretion in Response to Hypoxia
Authors:
Open Access
- 23 August 2010
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 5 (8) , e12360
Abstract
Tissue hypoxia is a consequence of decreased oxygen levels in different inflammatory conditions, many associated with mast cell activation. However, the effect of hypoxia on mast cell functions is not well established. Here, we have investigated the effect of hypoxia per se on human mast cell survival, mediator secretion, and reactivity. Human cord blood derived mast cells were subjected to three different culturing conditions: culture and stimulation in normoxia (21% O2); culture and stimulation in hypoxia (1% O2); or 24 hour culture in hypoxia followed by stimulation in normoxia. Hypoxia, per se, did not induce mast cell degranulation, but we observed an increased secretion of IL-6, where autocrine produced IL-6 promoted mast cell survival. Hypoxia did not have any effect on A23187 induced degranulation or secretion of cytokines. In contrast, cytokine secretion after LPS or CD30 treatment was attenuated, but not inhibited, in hypoxia compared to normoxia. Our data suggests that mast cell survival, degranulation and cytokine release are sustained under hypoxia. This may be of importance for host defence where mast cells in a hypoxic tissue can react to intruders, but also in chronic inflammations where mast cell reactivity is not inhibited by the inflammatory associated hypoxia.Keywords
This publication has 33 references indexed in Scilit:
- HLA class I supertypes: a revised and updated classificationBMC Immunology, 2008
- IgE alone promotes human lung mast cell survival through the autocrine production of IL-6BMC Immunology, 2008
- Expression of 15-lipoxygenase type-1 in human mast cellsBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2007
- Mast cells – key effector cells in immune responsesTrends in Immunology, 2007
- Ultraviolet B irradiation selectively increases the production of interleukin-8 in human cord blood-derived mast cellsClinical and Experimental Immunology, 2007
- Release of prostaglandin D2 and leukotriene C4 in response to hyperosmolar stimulation of mast cellsAllergy, 2006
- Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretionJournal of Clinical Investigation, 2006
- Ischaemia–reperfusion is an event triggered by immune complexes and complementBritish Journal of Surgery, 2003
- Induction of interleukin (IL)-6 by hypoxia is mediated by nuclear factor (NF)-κB and NF-IL6 in cardiac myocytesCardiovascular Research, 1999
- The mast cell and synovial inflammationArthritis & Rheumatism, 1984